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ORIGINAL ARTICLE

Comparison of Oral Versus Injectable Vitamin-D for the Treatment
of Nutritional Vitamin-D Deficiency Rickets
Abdul Gaffar Billoo1, Ghulam Murtaza2, M. Ashraf Memon3, Sultan Ahmed Khaskheli4, Khalid Iqbal4 and
Masood Hussain Rao5

ABSTRACT
Objective: To assess the safety and acceptability of a single dose of vitamin-D versus the efficacy of injectable
Vitamin-D versus oral vitamin-D.
Study Design: Case control.
Place and Duration of Study: It was carried out at the Department of Paediatrics, Kharadar General Hospital, Karachi,
from August 2003 to April 2004.
Methodology: Children of the age of 6 months to 3 years with clinical, biochemical and radiological evidence of vitaminD deficiency rickets were included. The history, clinical examination, complete blood picture, serum calcium. Phosphorus,
alkaline phosphatase and X-ray of wrist joint were done. The children were divided into two groups A and B. Group A was
given oral vitamin-D and group B was given intramuscular injection of vitamin-D on the first day and then they were
followed for two more visits at 30 and 90 days with clinical, biochemical and radiological examinations to assess
the outcome.
Results: There were 50 confirmed cases of rickets in each group. The mean age was 10.9+5.1 months and 14.7+8.1
months in group A and B respectively. In these children, clinical features were weakness, difficulty in walking, frontal
bossing, ribcage deformity and widening of wrist were seen. After one dose of vitamin-D (cholecalciferol), there was
appreciable gain of weight and height and raised levels of alkaline phosphatase became normal during follow-up.
Radiological florid rickets and non-florid rickets in both groups healed clinically during follow-up period. Oral and injectable
forms of vitamin-D (cholecalciferol) were effective but injectable form was shown to be statistically significant. There were
no undesirable side effects and both forms of treatment were well-tolerated.
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INTRODUCTION
Rickets is a common nutritional health problem in
children. Nutritional rickets causes considerable
childhood morbidity, disability and remains prevalent in
the developing countries of Asia. It is still present in
Pakistan’s urban economically and rural deprived
areas.1,2 It is unclear why rickets is so prevalent in
tropical countries with abundant sunlight which should
prevent vitamin-D deficiency. Its etiology is multifactorial
including inadequate dietary intake of vitamin-D,
reduced vitamin-D production in dark pigmented skin,
inadequate sun exposure because of air pollution,
infants remaining indoors, cereal-based diet with high
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phytate content, malabsorption, rapid growth of healthy
infant, prematurity and low-birth weight, vitamin-D
malnutrition in pregnant and lactating mothers and
prolonged therapy with anticonvulsant and genetic
factors.3-15 Children with nutritional rickets need
treatment to prevent them from severe consequences of
rickets. The standard treatment16 for nutritional rickets is
vitamin-D. Dietary Cholecalciferol (D3) and supplemental sources are important in prevention and
treatment of rickets in children. We conducted a
longitudinal case control study to compare the efficacy
of injectable vitamin-D (cholecalciferol) with single dose
oral vitamin-D, assess the safety and efficacy of it.

METHODOLOGY
This study was conducted at the Paediatric Outpatient
Department of Kharadar General Hospital, Karachi, from
August 2003 to April 2004. This was a clinical trial in
which 100 cases were enrolled. All children from 6
months to 3 years of age with clinical, biochemical and
radiological evidence of vitamin-D deficiency rickets
were included. Children under 6 months or more than 3
years of age, severely malnourished children with
rickets other than nutritional type, or presenting with
congenital abnormalities, serious illness during the
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study as follow-up or known hypersensitivity to the
product were excluded. After taking informed consent
from the parents, history and clinical examination was
done and complete blood picture, serum calcium,
phosphorus, alkaline phosphatase, and X-ray of wrist
joint were done and findings were recorded on
performa. Radiological criteria used to define active
rickets were osteopenia (bone demineralization),
widening of growth plate and metaphyseal cupping.17,18
Active rickets was further divided in florid and non-florid
type.13 Radiological evidence of healing was defined as
the presence of new calcification, reduced widening of
the growth plate compared with the baseline
radiograph.17,18 The children were divided into two
groups by stratified sampling. Children of group-A were
given vitamin-D (cholecalciferol) 200,000 i.u orally on
the day of induction (Do) in the study and children
assigned to group-B were given vitamin-D
(cholecalciferol) 200,000 i.u by intramuscular injection.
All children were further followed up for two more visits
on thirty (D30) and ninty (D90) days. In the follow-up visits
the children were subjected to clinical, biochemical and
radiological examination and their findings were
recorded. For statistical analysis, ANOVA (repeated
measured test) was applied to measure the statistical
difference of values in weight, height, hemoglobin and
biochemical results of first and follow-up visits. Pearson
Chi-square was applied to assess the radiological
findings of all patients in both groups. P-value <0.05 was
considered as statistically significant.

Table I: Baseline characteristics of both groups (oral and injectable
vitamin-D).
Characteristics
Age (months)
Mean+S.D
Range
Gender
Male
Female
Weight (Kg)
Day 1
Day 30th
Day 90th
Height (cm)
Day 1
Day 30th
Day 90th

Group A
(oral)

Baseline characteristics like age, gender, weight and
height are shown in Table I. Weight gain in both groups
is statistically significant and same in both groups, while
increase in height is statistically significant in group B
(injectable group). The symptoms and signs of both
groups are shown in Table II. The predominant symptom
was weakness (78-84%) and difficulty in walking
(74-78%) while signs like frontal bossing, ribcage
deformity and widening of wrists were predominant. The
hematological and biochemical findings of both groups
were compared as shown in Table III. Regarding
hematological investigations, the level of hemoglobin
improved and biochemically, the level of alkaline
phosphatase activity in both the groups became normal

Group B
(injectable)

10.9+5.1
24 (6-30)

14.7+8.1
28 (6-34)

36
14

1:0.39

7.6+1.5
7.9+1.5
8.6+1.4

0.012*

67.0+5.8
66.6+10.9
71.0+5.9

0.056**

27
23

P-value/ratio

----

1:0.85

8.1+2.0
8.7+2.0
9.0+2.0

0.027*

68.9+7.0
71.6+7.4
73.4+7.1

0.018*

*=Statistically significant at p<0.05; **=Not significant.

Table II: Symptoms and signs of both groups.
Symptoms
Weakness
Frequency of fall
Difficulty in walking
Leg pain during walking
Signs
Bossing of forehead
Wide anterior fontanel
Rib cage deformity
Harrison sulcus
Widening of wrist
Genu varum
Genu valgum
Widening of ankle

Group A (Oral)
42 (84%)
11 (22%)
37 (74%)
07 (14%)
32
26
29
16
37
05
23
11

(64%)
(52%)
(58%)
(32%)
(74%)
(10%)
(46%)
(22%)

Group B (Injectable)
39 (78%)
09 (18%)
39 (78%)
07 (14%)
28
21
33
11
41
07
27
10

(56%)
(42%)
(66%)
(22%)
(82%)
(14%)
(54%)
(20%)

Table III: Hematological and biochemical findings of both groups (oral
and injectable vitamin-D).

RESULTS
At the end of the study, the data was analyzed and
following observations were recorded. Hundred children
were enrolled, 50 in group A (oral) and 50 in group B
(injectable) according to the study inclusion criteria.
Ninety-six percent of children from group A and 94%
from group B completed the full study period. Two
patients from group A and 3 patients from group B were
lost during follow-up.

P-value/ratio

Group A
Mean +SD
A.
Hematological
Hemoglobin (gm%)
B.
Biochemical findings
I. Serum calcium
Day 1
Day 30th
Day 90th
II. Serum phosphorus
Day 1
Day 30th
Day 90th
III. Alkaline phosphatase
Day 1
Day 30th
Day 90th

P-value

9.4+1.2

Group B

P-value

9.3+1.4

8.7+0.9
8.9+0.8
8.8+0.7

0.2277**

8.2+1.2
8.7+1.0
8.7+0.9

0.026*

4.6+1.7
5.5+1.1
5.1+0.9

0.317**

4.7+1.5
5.0+1.0
4.9+1.1

0.898**

580+409
385+201
295+71

0.013*

687+498
469+314
309+149

0.009*

*= Statistically significant p<0.05; **= Not significant
Serum Calcium: 8.1-10.4mg/dl, Phosphorus: 4-7mg/dl,
Alkaline phosphatase: male (105-289 i.u), Female (97-278 i.u)

during the follow-up period (Table IV). Statistically, the
level of calcium was raised in both the groups
significantly, while alkaline phosphatase level was
reduced in both groups but more (p<0.01) in group B.
Radiologically, 58.3% cases in group-A and 59.57% in
group-B had shown active florid rickets before
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Table IV:Alkaline phoshatase levels and radiological severity of
rickets.

*Alkaline phosphatase
Upto 500 i.u
500-1000 i.u
>1000 i.u
Radiological findings
**Florid rickets
**Non-florid rickets

Group A
n-48

Group B
n-47

28
11
9

20
18
9

28
20

28
19

*Alkaline phosphatase: male (105-289 i.u), Female (97-278 i.u).
* *Florid rickets13 (osteopenia, widened growth plate, metaphyseal concavity with fraying).
** Non-florid rickets (osteopenia, widened growth plate, irregularity of metaphyseal margin but
without concave cupping).

administration of therapy and all of them showed signs
of healed rickets during their subsequent visits.
Regarding the route of administration of vitamin-D
(cholecalciferol), it was seen that the parents preferred
the injectable route. There were no undesirable side
effects observed in either groups and both oral and
injectable forms of the treatment were well-tolerated.

observation was the hemoglobin level improved as
compared to the level prior to the administration of
vitamin D (cholecalciferol). A high degree of association
between iron deficiency anemia and vitamin-D
deficiency has been observed.24 Low plasma vitamin D
and iron deficiency anaemia often coexist.25 Iron
deficiency was found to be a significant risk factor for
low vitamin-D. Alkaline phosphatase level remains a
reliable and economic biochemical marker for
diagnosing vitamin-D deficiency rickets and monitoring
the effectiveness of treatment in the clinical setting.26
Radiologically, all cases of rickets (florid or non-florid)
showed healed rickets during their subsequent visits.
There were no undesirable side effects observed in
either group of children and both oral and injectable
forms of treatment were well-tolerated. Cost of oral and
injectable vitamin-D was almost same. Regarding route
of administration of cholecalciferol, the parents
preferred intramuscular route.

CONCLUSION

DISCUSSION
In this study, the clinical efficacy of injectable versus oral
form of cholecalciferol was compared. There were 50
children in each group. The average age in this study
was 10.9+5.1 months in group A and 14.7+8.1 months
in group B. In a local study from Lahore, age of rickets
children were in the range of 6-11 months.19 In African
country – Ethiopia, rickets children were 6-18 months20
while in Middle East country – Kuwait, the children were
under one year.21 The male to female ratio was 1:0.4
and 1:0.9 in group A and B respectively. Preponderance
of male children in both groups was observed as seen in
one of the study from Karachi2 with 62% of male, and in
Peshawar,6 the male children were 62%, while a study
from Lahore,19 recognised male gender as a risk factor.
Kharadar General Hospital is located in the old city area
of Karachi and comprises of a population of mostly
lower and middle classes. The majority of population live
in multi-storied congested apartments or small houses
with one or two rooms devoid of sunlight and without
any courtyards. The women and children wear the local
dress (shalwar kameez), which covers most of the skin
surfaces except face and hands. The body characteristics like weight and height showed improvement as
compared to their first visit prior to oral or injectable
dose of vitamin-D (as shown in Table I). In clinical
symptoms and signs, the majority of parents/guardians
highlighted the symptoms of weakness which is difficult
to explain in young infants, possibly it is attributed to
hypotonia, which is seen in rickets. Progressive
weakness of proximal muscles is a feature of rickets.22
Difficulty in walking, frequent falls, pain in the hands and
legs were seen,23 while in signs widening of wrists,
frontal bossing, wide anterior fontanel and rib cage
deformity were predominantly seen. An additional
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Vitamin-D (cholecalciferol) is effective in the treatment of
nutritional vitamin-D rickets in both intramuscular and
oral form. The clinical efficacy of vitamin-D (cholecalciferol) by both routes is equaly good and there are no
side effects in either form. Oral vitamin-D (cholecalciferol; 200,000 i.u) is as effective in the treatment of
nutritional vitamin-D deficiency rickets as injectable.
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